Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,265
archived clinical trials in
Crohns Disease

A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated:  4/9/2013
Gastroenterology Group of Naples
1273
mi
from 02139
Naples, FL
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated: 4/9/2013
Gastroenterology Group of Naples
1273
mi
from 02139
Naples, FL
Click here to add this to my saved trials
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated:  4/9/2013
Shafran Gastroenterology Center
1110
mi
from 02139
Winter Park, FL
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated: 4/9/2013
Shafran Gastroenterology Center
1110
mi
from 02139
Winter Park, FL
Click here to add this to my saved trials
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated:  4/9/2013
Atlanta Gastroenterology Associates
927
mi
from 02139
Atlanta, GA
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated: 4/9/2013
Atlanta Gastroenterology Associates
927
mi
from 02139
Atlanta, GA
Click here to add this to my saved trials
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated:  4/9/2013
Gastroenterology Associates of Central Georgia
948
mi
from 02139
Macon, GA
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated: 4/9/2013
Gastroenterology Associates of Central Georgia
948
mi
from 02139
Macon, GA
Click here to add this to my saved trials
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated:  4/9/2013
University of Chicago Hospital Medical Center
846
mi
from 02139
Chicago, IL
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated: 4/9/2013
University of Chicago Hospital Medical Center
846
mi
from 02139
Chicago, IL
Click here to add this to my saved trials
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated:  4/9/2013
University of Louisville School of Medicine
821
mi
from 02139
Louisville, KY
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated: 4/9/2013
University of Louisville School of Medicine
821
mi
from 02139
Louisville, KY
Click here to add this to my saved trials
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated:  4/9/2013
Metropolitan Gastroenterology Group, P.C.
390
mi
from 02139
Chevy Chase, MD
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated: 4/9/2013
Metropolitan Gastroenterology Group, P.C.
390
mi
from 02139
Chevy Chase, MD
Click here to add this to my saved trials
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated:  4/9/2013
Endoscopic Microsurgery Associates
353
mi
from 02139
Towson, MD
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated: 4/9/2013
Endoscopic Microsurgery Associates
353
mi
from 02139
Towson, MD
Click here to add this to my saved trials
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated:  4/9/2013
MedRACS
10
mi
from 02139
Quincy, MA
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated: 4/9/2013
MedRACS
10
mi
from 02139
Quincy, MA
Click here to add this to my saved trials
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated:  4/9/2013
Clinical Research Institute of Michigan,
613
mi
from 02139
Chesterfield, MI
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated: 4/9/2013
Clinical Research Institute of Michigan,
613
mi
from 02139
Chesterfield, MI
Click here to add this to my saved trials
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated:  4/9/2013
Center for Digestive Health
613
mi
from 02139
Troy, MI
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated: 4/9/2013
Center for Digestive Health
613
mi
from 02139
Troy, MI
Click here to add this to my saved trials
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated:  4/9/2013
Digestive Health Center
1280
mi
from 02139
Ocean Springs, MS
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated: 4/9/2013
Digestive Health Center
1280
mi
from 02139
Ocean Springs, MS
Click here to add this to my saved trials
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated:  4/9/2013
St. Louis Center for Clinical Research
1045
mi
from 02139
St. Louis, MO
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated: 4/9/2013
St. Louis Center for Clinical Research
1045
mi
from 02139
St. Louis, MO
Click here to add this to my saved trials
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated:  4/9/2013
Long Island Clinical Research Associates, LLP
173
mi
from 02139
Great Neck, NY
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated: 4/9/2013
Long Island Clinical Research Associates, LLP
173
mi
from 02139
Great Neck, NY
Click here to add this to my saved trials
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated:  4/9/2013
NY Scientific CORP
178
mi
from 02139
Hollis, NY
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated: 4/9/2013
NY Scientific CORP
178
mi
from 02139
Hollis, NY
Click here to add this to my saved trials
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated:  4/9/2013
Pmg Research Of Salisbury
682
mi
from 02139
Salisbury, NC
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated: 4/9/2013
Pmg Research Of Salisbury
682
mi
from 02139
Salisbury, NC
Click here to add this to my saved trials
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated:  4/9/2013
PMG Research of Winston-Salem
652
mi
from 02139
Winston-Salem, NC
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated: 4/9/2013
PMG Research of Winston-Salem
652
mi
from 02139
Winston-Salem, NC
Click here to add this to my saved trials
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated:  4/9/2013
Consultants for Clinical Research Inc.
735
mi
from 02139
Cincinnati, OH
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated: 4/9/2013
Consultants for Clinical Research Inc.
735
mi
from 02139
Cincinnati, OH
Click here to add this to my saved trials
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated:  4/9/2013
Ohio Gastroenterology and Liver
735
mi
from 02139
Cincinnati, OH
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated: 4/9/2013
Ohio Gastroenterology and Liver
735
mi
from 02139
Cincinnati, OH
Click here to add this to my saved trials
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated:  4/9/2013
Advanced Research Institute
2087
mi
from 02139
Ogden, UT
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated: 4/9/2013
Advanced Research Institute
2087
mi
from 02139
Ogden, UT
Click here to add this to my saved trials
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated:  4/9/2013
University of Utah
2088
mi
from 02139
Salt Lake City, UT
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated: 4/9/2013
University of Utah
2088
mi
from 02139
Salt Lake City, UT
Click here to add this to my saved trials
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated:  4/9/2013
University of Washington Medical Center
2481
mi
from 02139
Seattle, WA
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated: 4/9/2013
University of Washington Medical Center
2481
mi
from 02139
Seattle, WA
Click here to add this to my saved trials
L-carnitine to Treat Fatigue Associated With Crohn's Disease
L-carnitine to Treat Fatigue Associated With Crohn's Disease
Status: Enrolling
Updated:  5/15/2013
UCSF Medical Center, Mt. Zion Medical Center
2690
mi
from 02139
San Francisco, CA
L-carnitine to Treat Fatigue Associated With Crohn's Disease
L-carnitine to Treat Fatigue Associated With Crohn's Disease
Status: Enrolling
Updated: 5/15/2013
UCSF Medical Center, Mt. Zion Medical Center
2690
mi
from 02139
San Francisco, CA
Click here to add this to my saved trials
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated:  5/23/2013
GSK Investigational Site
2293
mi
from 02139
Glendale, AZ
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated: 5/23/2013
GSK Investigational Site
2293
mi
from 02139
Glendale, AZ
Click here to add this to my saved trials
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated:  5/23/2013
GSK Investigational Site
2571
mi
from 02139
Anaheim, CA
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated: 5/23/2013
GSK Investigational Site
2571
mi
from 02139
Anaheim, CA
Click here to add this to my saved trials
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated:  5/23/2013
GSK Investigational Site
1756
mi
from 02139
Aurora, CO
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated: 5/23/2013
GSK Investigational Site
1756
mi
from 02139
Aurora, CO
Click here to add this to my saved trials
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated:  5/23/2013
GSK Investigational Site
118
mi
from 02139
New Haven, CT
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated: 5/23/2013
GSK Investigational Site
118
mi
from 02139
New Haven, CT
Click here to add this to my saved trials
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated:  5/23/2013
GSK Investigational Site
1017
mi
from 02139
Jacksonville, FL
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated: 5/23/2013
GSK Investigational Site
1017
mi
from 02139
Jacksonville, FL
Click here to add this to my saved trials
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated:  5/23/2013
GSK Investigational Site
918
mi
from 02139
Roswell, GA
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated: 5/23/2013
GSK Investigational Site
918
mi
from 02139
Roswell, GA
Click here to add this to my saved trials
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated:  5/23/2013
GSK Investigational Site
874
mi
from 02139
Joliet, IL
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated: 5/23/2013
GSK Investigational Site
874
mi
from 02139
Joliet, IL
Click here to add this to my saved trials
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated:  5/23/2013
GSK Investigational Site
821
mi
from 02139
Louisville, KY
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated: 5/23/2013
GSK Investigational Site
821
mi
from 02139
Louisville, KY
Click here to add this to my saved trials
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated:  5/23/2013
GSK Investigational Site
1378
mi
from 02139
Baton Rouge, LA
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated: 5/23/2013
GSK Investigational Site
1378
mi
from 02139
Baton Rouge, LA
Click here to add this to my saved trials
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated:  5/23/2013
GSK Investigational Site
390
mi
from 02139
Bethesda, MD
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated: 5/23/2013
GSK Investigational Site
390
mi
from 02139
Bethesda, MD
Click here to add this to my saved trials
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated:  5/23/2013
GSK Investigational Site
2
mi
from 02139
Boston, MA
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated: 5/23/2013
GSK Investigational Site
2
mi
from 02139
Boston, MA
Click here to add this to my saved trials
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated:  5/23/2013
GSK Investigational Site
734
mi
from 02139
Grand Rapids, MI
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated: 5/23/2013
GSK Investigational Site
734
mi
from 02139
Grand Rapids, MI
Click here to add this to my saved trials
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated:  5/23/2013
GSK Investigational Site
1079
mi
from 02139
Rochester, MN
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated: 5/23/2013
GSK Investigational Site
1079
mi
from 02139
Rochester, MN
Click here to add this to my saved trials
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated:  5/23/2013
GSK Investigational Site
1050
mi
from 02139
Chesterfield, MO
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated: 5/23/2013
GSK Investigational Site
1050
mi
from 02139
Chesterfield, MO
Click here to add this to my saved trials
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated:  5/23/2013
GSK Investigational Site
180
mi
from 02139
New York, NY
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated: 5/23/2013
GSK Investigational Site
180
mi
from 02139
New York, NY
Click here to add this to my saved trials
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated:  5/23/2013
GSK Investigational Site
607
mi
from 02139
Durham, NC
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated: 5/23/2013
GSK Investigational Site
607
mi
from 02139
Durham, NC
Click here to add this to my saved trials
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated:  5/23/2013
GSK Investigational Site
733
mi
from 02139
Cincinnati, OH
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated: 5/23/2013
GSK Investigational Site
733
mi
from 02139
Cincinnati, OH
Click here to add this to my saved trials
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated:  5/23/2013
GSK Investigational Site
1548
mi
from 02139
Weatherford, OK
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated: 5/23/2013
GSK Investigational Site
1548
mi
from 02139
Weatherford, OK
Click here to add this to my saved trials
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated:  5/23/2013
GSK Investigational Site
2554
mi
from 02139
Klamath Falls, OR
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated: 5/23/2013
GSK Investigational Site
2554
mi
from 02139
Klamath Falls, OR
Click here to add this to my saved trials
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated:  5/23/2013
GSK Investigational Site
270
mi
from 02139
Philadelphia, PA
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated: 5/23/2013
GSK Investigational Site
270
mi
from 02139
Philadelphia, PA
Click here to add this to my saved trials
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated:  5/23/2013
GSK Investigational Site
816
mi
from 02139
Knoxville, TN
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated: 5/23/2013
GSK Investigational Site
816
mi
from 02139
Knoxville, TN
Click here to add this to my saved trials
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated:  5/23/2013
GSK Investigational Site
2088
mi
from 02139
Salt Lake City, UT
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated: 5/23/2013
GSK Investigational Site
2088
mi
from 02139
Salt Lake City, UT
Click here to add this to my saved trials
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated:  5/23/2013
GSK Investigational Site
472
mi
from 02139
Richmond, VA
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated: 5/23/2013
GSK Investigational Site
472
mi
from 02139
Richmond, VA
Click here to add this to my saved trials
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated:  5/23/2013
GSK Investigational Site
2355
mi
from 02139
Kennewick, WA
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated: 5/23/2013
GSK Investigational Site
2355
mi
from 02139
Kennewick, WA
Click here to add this to my saved trials
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated:  5/23/2013
GSK Investigational Site
1017
mi
from 02139
La Crosse, WI
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated: 5/23/2013
GSK Investigational Site
1017
mi
from 02139
La Crosse, WI
Click here to add this to my saved trials
A RETROspective Data Collection of comPRESSion Anastomosis Using the ColonRing
Multi Center, Observational, Retrospective Data Collection of Patients Treated With the ColonRing in Routine Clinical Practice. This Study to Continue RETROPRESS Study ID NCT01301417
Status: Enrolling
Updated:  6/16/2013
Florida Hospital, Center for Colon & Rectal Surgery
1106
mi
from 02139
Atlamonte Springs, FL
A RETROspective Data Collection of comPRESSion Anastomosis Using the ColonRing
Multi Center, Observational, Retrospective Data Collection of Patients Treated With the ColonRing in Routine Clinical Practice. This Study to Continue RETROPRESS Study ID NCT01301417
Status: Enrolling
Updated: 6/16/2013
Florida Hospital, Center for Colon & Rectal Surgery
1106
mi
from 02139
Atlamonte Springs, FL
Click here to add this to my saved trials
A RETROspective Data Collection of comPRESSion Anastomosis Using the ColonRing
Multi Center, Observational, Retrospective Data Collection of Patients Treated With the ColonRing in Routine Clinical Practice. This Study to Continue RETROPRESS Study ID NCT01301417
Status: Enrolling
Updated:  6/16/2013
18308 Murdock Circle, Suite 108
1230
mi
from 02139
Port Charlotte, FL
A RETROspective Data Collection of comPRESSion Anastomosis Using the ColonRing
Multi Center, Observational, Retrospective Data Collection of Patients Treated With the ColonRing in Routine Clinical Practice. This Study to Continue RETROPRESS Study ID NCT01301417
Status: Enrolling
Updated: 6/16/2013
18308 Murdock Circle, Suite 108
1230
mi
from 02139
Port Charlotte, FL
Click here to add this to my saved trials